Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin in Adults With Nonalcoholic Fatty Liver Disease

NCT04031729 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04031729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04031729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin in Adults With Nonalcoholic Fatty Liver Disease
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 12, 2019
Completion date
February 23, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver, nonalcoholic steatohepatitis